Kigali facility revs up Africa's vaccine self-reliance

Kigali facility revs up Africa's vaccine self-reliance

Backed by fresh European financing, BioNTech’s Kigali facility is emerging as the cornerstone of Africa’s mRNA vaccine ecosystem, bridging the gap between ambition and large-scale production. SPECIAL REPORT | BIRD AGENCY | A new European financial backing of BioNTech’s mRNA vaccine facility in Kigali marks a defining step in Africa’s long-term pursuit of health and industrial self-reliance, moving the continent’s vaccine manufacturing ambitions …